FDA Inspection 1020358 — Jiangsu YongAn Pharmaceutical Co., Ltd
The FDA completed an inspection of Jiangsu YongAn Pharmaceutical Co., Ltd on July 7, 2017 in Huaian. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- July 7, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Huaian (China)